Approval · Notice of Compliance 9772 · 2008
BONEFOS: Notice of Compliance 9772
Issued September 8, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9772
- Date
- September 8, 2008
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the following sections of the product monograph: warnings and precautions, adverse reactions, dosage and administration, overdosage, and consumer information
- Therapeutic class
- Bone metabolism regulator (anti-hypercalcemic agent)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BONEFOS | Not yet assigned | — |
Medicinal ingredients
- CLODRONATE DISODIUM TETRAHYDRATE 400 MG per CAP
- CLODRONATE DISODIUM TETRAHYDRATE 60 MG per ML